Latest News and Press Releases

At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patientsNew active pharmaceutical ingredients facility in North Carolina...

At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patientsNew active pharmaceutical ingredients facility in North Carolina...

Zurich, 30 April 2026 – 21shares, a global leader in cryptocurrency exchange-traded products (ETPs), has successfully transitioned the underlying index provider for a broad segment of its European...

Ad hoc announcement pursuant to Art. 53 LR. Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent...

Ad-hoc-Mitteilung gemäss Art. 53 KR.  Pratteln, Schweiz, 30. April 2026 – Santhera Pharmaceuticals (SIX: SANN) schlägt vor, Dr. Srishti Gupta, MD, MPP, MPhil, auf der bevorstehenden ordentlichen...

New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing...

GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive activity in multiple disease modelsContinued to reposition dipraglurant mGlu5 NAM for brain injury...

Luxembourg, April 30, 2026 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated...

21Shares AG, the issuer of ETPs listed on various trading venues, has published its financialstatements for the financial year ending 31 December 2025. The financial statements are available...

21Shares AG, the issuer of ETPs listed on various trading venues, has published its financialstatements for the financial year ending 31 December 2025. The financial statements are available...